DeepVerge Past Earnings Performance
Past criteria checks 0/6
DeepVerge has been growing earnings at an average annual rate of 41.9%, while the Life Sciences industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 82.6% per year.
Key information
41.9%
Earnings growth rate
56.0%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 82.6% |
| Return on equity | -10.9% |
| Net Margin | -19.8% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How DeepVerge makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 12 | -2 | 7 | 0 |
| 31 Mar 22 | 11 | -3 | 6 | 0 |
| 31 Dec 21 | 9 | -3 | 6 | 0 |
| 30 Sep 21 | 8 | -3 | 5 | 0 |
| 30 Jun 21 | 7 | -4 | 5 | 0 |
| 31 Mar 21 | 6 | -3 | 4 | 0 |
| 31 Dec 20 | 4 | -3 | 3 | 0 |
| 30 Jun 20 | 1 | -2 | 2 | 0 |
| 31 Mar 20 | 1 | -2 | 2 | 0 |
| 31 Dec 19 | 1 | -2 | 2 | 0 |
| 30 Jun 19 | 1 | -2 | 1 | 0 |
| 31 Mar 19 | 0 | -2 | 1 | 0 |
| 31 Dec 18 | 0 | -1 | 1 | 0 |
| 30 Jun 18 | 0 | -4 | 1 | 0 |
| 31 Mar 18 | 0 | -5 | 1 | 0 |
| 31 Dec 17 | 0 | -5 | 1 | 0 |
| 30 Sep 17 | 0 | -5 | 2 | 0 |
| 30 Jun 17 | 0 | -2 | 1 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
Quality Earnings: 4RG is currently unprofitable.
Growing Profit Margin: 4RG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 4RG's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 4RG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4RG is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (12.2%).
Return on Equity
High ROE: 4RG has a negative Return on Equity (-10.88%), as it is currently unprofitable.